Effects of cilostazol against the progression of carotid IMT in symptomatic ischemic stroke patients
Carotid intima-media thickness (IMT) is a surrogate marker for evaluating atherosclerotic vascular diseases. The phosphodiesterase inhibitor cilostazol attenuates the increase in carotid IMT in diabetes patients. We studied whether cilostazol can reduce the progression of carotid IMT in symptomatic...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535378/ |